ClinicalTrials.gov
ClinicalTrials.gov Menu

A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01143246
Recruitment Status : Completed
First Posted : June 14, 2010
Last Update Posted : September 23, 2016
Sponsor:
Information provided by (Responsible Party):
Mallinckrodt